In this comprehensive webinar hosted by Rheuma TV, Dr. Puja Srivastava breaks down the transition of JAK inhibitors from bench concept to clinical application in rheumatology.
Mechanism of Action: Explores the JAK-STAT signal transduction pathway and its critical role in the pathogenesis of autoimmune diseases.
Clinical Efficacy: Reviews clinical trial data and real-world efficacy in treating autoimmune conditions like Rheumatoid Arthritis.
Safety & Screening: Highlights safety monitoring protocols, mandatory baseline screening, and risk mitigation strategies.
Contraindications & Risk Profiles: Discusses clinical precautions regarding pregnancy, breastfeeding, recurrent infections, venous thromboembolism (DVT/PE risk), and diverticulitis.